Department of Hepatology Key Laboratory of Extracorporeal Life Support for Critical Diseases University Affiliated Third Center Hospital 300170;
Department of Hepatobiliary Surgery First Central Hospital 300192;
Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases University Affiliated Third Center Hospital 300170;
Tianjin Institute of Hepatobiliary Disease Third Central Clinical College of Tianjin Medical University 300170;
Recurrent hepatocellular carcinoma; Local regional therapy; Systemic therapy; Tumor microenvironment; Recurrence type; Immune checkpoint inhibitors;